Skip to main content
    F

    Fresenius Medical Care Corporation (FMS)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $22.03
    +0.43 (+1.99%)

    Market Cap: $11.43B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Fresenius Medical Care Corporation (FMS) Financials: Revenue, Profit and Cash Flow

    Updated Nov 3, 2026. Financial statements from company filings, amounts in EUR.

    Fresenius Medical Care reported revenue of EUR 19.63B for the fiscal year ended Dec 31, 2025, up 1.5% from the year before. That year, net income was EUR 978.37M with a net margin of 5.0%, operating cash flow was EUR 2.58B and free cash flow was EUR 1.70B. The quarter ended Sep 30, 2026 had revenue of EUR 4.94B and net income of EUR 159.78M.

    Revenue and Margins

    The operating margin was 9.3% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from EUR 17.03B, a compound annual rate of 1.6%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 202519.63B+1.5%25.6%9.3%5.0%
    Dec 202419.34B-0.6%24.6%7.6%2.8%
    Dec 202319.45B+0.3%25.3%7.0%2.6%
    Dec 202219.40B+10.1%25.2%7.8%3.5%
    Dec 202117.62B-1.3%27.1%10.5%5.5%
    Dec 202017.86B+2.2%31.0%12.9%6.5%
    Dec 201917.48B+5.6%30.9%13.0%6.9%
    Dec 201816.55B-7.0%31.2%18.4%12.0%
    Dec 201717.78B+4.4%33.8%13.3%7.2%
    Dec 201617.03BN/A32.3%14.7%6.9%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 81.9% from the year before. In the quarter ended Sep 2026, net income fell 41.9% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue19.63B19.34B19.45B19.40B17.62B17.86B17.48B16.55B17.78B17.03B
    Cost of revenue14.60B14.58B14.53B14.50B12.85B12.32B12.08B11.39B11.78B11.53B
    Gross profit5.03B4.76B4.93B4.89B4.77B5.54B5.40B5.16B6.00B5.50B
    Research and development157.97M183.49M231.97M228.62M220.78M193.77M168.03M134.00M131.00M154.04M
    Operating income1.83B1.47B1.37B1.51B1.85B2.30B2.27B3.04B2.36B2.51B
    Net income978.37M537.91M499.00M673.40M969.31M1.16B1.20B1.98B1.28B1.18B
    EBITDA3.40B3.21B3.21B3.42B3.55B4.13B3.92BN/A3.15B3.17B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue4.94B4.86B4.61B5.07B4.88B4.79B4.88B5.08B4.76B4.77B4.72B4.99B
    Gross profit1.28B1.31B1.18B1.39B1.24B1.21B1.18B1.27B1.15B1.17B1.17B1.35B
    Operating income374.64M465.86M375.56M548.98M501.72M394.40M381.73M398.93M462.70M425.00M246.01M427.65M
    Net income159.78M218.38M117.53M327.08M274.80M225.27M151.22M66.90M213.03M187.00M70.96M187.93M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of EUR 7.89B exceeded cash and equivalents by 6.29B.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets31.00B33.57B33.93B35.75B34.37B31.69B32.93B26.24B24.03B25.50B
    Current assets7.90B7.92B8.70B8.20B7.97B7.28B7.17B7.85B6.37B6.88B
    Cash and equivalents1.60B1.18B1.40B1.27B1.48B1.08B1.01B2.15B978.11M708.88M
    Total liabilities16.72B17.80B19.10B20.30B20.39B19.36B19.71B13.34B13.20B14.45B
    Short-term debt2.20B1.22B1.56B2.02B2.59B1.70B3.26B2.50B1.65B1.30B
    Long-term debt5.69B6.26B6.96B7.17B6.65B6.80B6.46B5.02B5.77B6.80B
    Shareholder equity14.28B14.58B13.62B13.99B12.70B12.33B11.96B11.76B9.82B9.98B
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets31.45B31.29B31.47B31.00B30.89B31.29B32.74B33.57B32.51B33.90B34.34B33.93B
    Total liabilities17.69B17.76B17.26B16.72B16.98B16.96B17.23B17.80B17.72B18.71B19.20B19.10B
    Cash and equivalents1.10B1.06B1.24B1.60B1.26B1.72B1.07B1.18B1.37B1.09B1.15B1.40B
    Shareholder equity12.79B12.56B13.24B14.28B12.95B13.27B14.37B14.58B13.62B13.93B13.91B13.62B
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 65.9% of operating cash flow. Dividends came to 23.9% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow2.58B2.39B2.63B2.17B2.49B4.23B2.57B2.06B2.19B2.03B
    Capital expenditures879.24M699.36M684.60M1.41B1.68B2.09B2.24B2.06B1.78B1.94B
    Free cash flow1.70B1.69B1.94B756.00M806.00M2.15B329.00M2.00M407.00M93.18M
    Dividends paid405.84M349.16M328.62M395.56M392.45M351.17M354.64M324.84M293.97MN/A
    Investing cash flow-666.18M-84.94M-544.23M-734.73M-1.20B-1.33B-3.29B-245.04M-991.54MN/A
    Financing cash flow-1.38B-2.57B-1.86B-1.62B-1.02B-2.66B-466.63M-681.74M-798.63MN/A
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow797.56M860.30M226.89M974.54M741.56M774.93M162.82M831.70M984.71M442.42M127.31M719.07M
    Capital expenditures237.97M240.40M190.07M410.42M192.21M154.38M145.76M240.69M165.35M159.42M133.90M250.28M
    Free cash flow559.59M619.90M36.82M564.11M549.35M620.55M17.06M591.01M819.36M283.01M-6.59M468.79M
    Last 12 quarters

    Frequently Asked Questions About FMS

    What is Fresenius Medical Care's annual revenue?

    Fresenius Medical Care reported revenue of EUR 19.63B for the fiscal year ended Dec 31, 2025.

    How fast is Fresenius Medical Care's revenue growing?

    Revenue was up 1.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 0.4%.

    Is Fresenius Medical Care profitable?

    Yes. Fresenius Medical Care reported net income of EUR 978.37M for the fiscal year ended Dec 31, 2025, with a net margin of 5.0%.

    How much free cash flow does FMS generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of EUR 2.58B minus capital expenditures of EUR 879.24M produced free cash flow of EUR 1.70B.

    How much debt does Fresenius Medical Care have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of EUR 5.69B, short-term debt of EUR 2.20B and cash and equivalents of EUR 1.60B.